共 21 条
- [1] Carter S.K., Friedman M.A., 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—A new antitumor agent with activity against malignant melanoma, Eur J Cancer, 8, pp. 85-92, (1972)
- [2] Slavik M., Clinical studies with DTIC (NSC-45388) in various malignancies, Cancer Treat Rep, 60, pp. 213-214, (1976)
- [3] Carter S.K., Slavik M., Chemotherapy of cancer, Annu Rev Pharmacol, 14, pp. 157-183, (1974)
- [4] Bono V.H., Studies on the mechanism of action of DTIC (NSC-45388), Cancer Treat Rep, 60, pp. 141-148, (1960)
- [5] Shealy Y.F., Krauth C.A., Montgomery J.A.I., Coupling reactions of 5-Diazoimidazole- 4-carboxamide, J Org Chem, 27, pp. 2150-2154, (1962)
- [6] Shealy Y.F., Krauth C.A., Clayton S.J., Shortnacy A.T., Laster W.R.V., . 5(or 4)-(3-alkyl-3-methyl-1-triazeno)imidazole-4(or 5)-carboxamides, J Pharm Sci, 57, pp. 1562-1568, (1968)
- [7] Horton J.K., Stevens M.F.G., A new light on the photo-decomposition of the antitumour drug DTIC, J Pharm Pharmacol, 33, pp. 808-811, (1981)
- [8] El Aatmani M., Poujol S., Astre C., Malosse F., Pinguet F., Stability of dacarbazine in amber glass vials and polyvinyl chloride bags, Am J Health Syst Pharm, 59, pp. 1351-1356, (2002)
- [9] Shetty B.V., Schowen R.L., Slavik M., Riley C.M., Degradation of dacarbazine in aqueous solution, J Pharm Biomed Anal, 10, pp. 675-683, (1992)
- [10] Bahrpeyma S., Hemmateenejad B., Javidnia K., Photo-degradation study of dacarbazine by spectrophotometric–chemometrics and HPLC methods, J Iran Chem Soc, 13, pp. 221-229, (2016)